Rescigno, Pasquale

Genomic correlates of clinical outcome in advanced prostate cancer

Abida, W., Cyrta, J., Heller, G., Prandi, D., Armenia, J., Coleman, I., Cieslik, M., Benelli, M., Robinson, D., Van Allen, E. M., et al. (2019) · Proceedings of the National Academy of Sciences

Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer

Cited by 1,372

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Paschalis, A., Sheehan, B., Riisnaes, R., Rodrigues, D. N., Gurel, B., Bertan, C., Ferreira, A., Lambros, M. B. K., Seed, G., Yuan, W., et al. (2019) · European Urology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 455

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis

Pernigoni, N., Zagato, E., Calcinotto, A., Troiani, M., Mestre, R. P., Calì, B., Attanasio, G., Troisi, J., Minini, M., Mosole, S., et al. (2021) · Science

Prostate Cancer Treatment and ResearchGut microbiota and health

Cited by 323

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

Ferraldeschi, R., Nava Rodrigues, D., Riisnaes, R., Miranda, S., Figueiredo, I., Rescigno, P., Ravi, P., Pezaro, C., Omlin, A., Lorente, D., et al. (2015) · European Urology

Prostate Cancer Treatment and ResearchPI3K/AKT/mTOR signaling in cancer

Cited by 268

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

Boysen, G., Rodrigues, D. N., Rescigno, P., Seed, G., Dolling, D., Riisnaes, R., Crespo, M., Zafeiriou, Z., Sumanasuriya, S., Bianchini, D., et al. (2018) · Clinical Cancer Research

Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer

Cited by 145

HER3 Is an Actionable Target in Advanced Prostate Cancer

Gil, V., Miranda, S., Riisnaes, R., Gurel, B., D’Ambrosio, M., Vasciaveo, A., Crespo, M., Ferreira, A., Brina, D., Troiani, M., et al. (2021) · Cancer Research

Prostate Cancer Treatment and ResearchHER2/EGFR in Cancer Research

Cited by 68

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis

Messina, C., Giunta, E. F., Signori, A., Rebuzzi, S. E., Banna, G. L., Maniam, A., Buti, S., Cattrini, C., Fornarini, G., Bauckneht, M., et al. (2024) · European Urology Oncology

Prostate Cancer Treatment and ResearchPARP inhibition in cancer therapy

Cited by 39

New Perspectives in the Therapy of Castration Resistant Prostate Cancer

Rescigno, P., Buonerba, C., Bellmunt, J., Sonpavde, G., De Placido, S., & Di Lorenzo, G. (2012) · Current Drug Targets

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 37